AIDS 2016: HIV Stigma Persists in the Undetectable Era


In an era of widespread HIV treatment and undetectable viral load, stigma remains a persistent feature in the lives of almost half of people living with diagnosed HIV in the U.K., according to findings from The People Living with HIV Stigma Survey UK 2015, reported at the 21st International AIDS Conference (AIDS 2016) last week in Durban. Nonetheless the majority of people with HIV score highly on measures of psychological resilience, enabling them to cope better with stigma.

[Produced in collaboration with]

A total of 1576 people recruited from 120 community organizations and 47 HIV clinics throughout the United Kingdom completed an anonymous online survey. Participants broadly represented the demography of people accessing HIV care in the U.K. In addition, 40 semi-structured interviews were carried out with a sub-sample.

Instances of anticipated stigma (the person with HIV expecting someone else to have a poor opinion or bad reaction to them) were reported during almost all in-depth interviews. For example, one woman said:

"In my church I’ve never really alluded to having HIV, because I don’t know how they would think."

Anticipated stigma was most often experienced when considering talking about HIV status with a potential sexual partner.

"It’s amazing that despite the advances in treatment, people’s attitudes are still exactly the same. The same as a long time ago, when it first started."

Nonetheless, understandings of the impact of antiretroviral treatment on infectiousness had empowered some people.

"I think it’s given people living with HIV more confidence. A lot more people are now saying, I’m not infectious, fine, then I’ll go ahead and be a bit more confident in trying to find someone to date."

The researchers measured participants’ resilience, using 10 questions and a validated scale. For example, in response to the statement "I tend to bounce back after hardships," 63% said this was often or nearly always true. In relation to "I am able to handle unpleasant or painful feelings," 52% said this was often or nearly always true.

Overall, 27% of respondents had low resilience, 39% had medium resilience, and 34% had high resilience.

Those with low resilience were more likely to experience stigma and to report negative experiences of living with HIV. Specifically, they were more likely than people with high resilience to have been diagnosed with depression (71% vs 22%), to have experienced social discrimination (46% vs 23%), to have experienced anxiety (53% vs 24%), or to have avoided social or sexual experiences (54% vs 32%).

Thematic analysis of participants’ experiences of living with HIV identified that those with low resilience most commonly reported social isolation and negative experiences, whereas those with high resilience focused on adopting healthier behaviors and empowering experiences.

Resilience was an important theme during in-depth interviews:

"I do not feel I require others’ acceptance or approval. I do not feel this status fundamentally changes the person I am but my willingness to believe in myself as undiminished has required of me to dig deep within and be courageous."

"I was diagnosed with a CD4 count of 10. My CD4 was in between life and death, it’s a thin line…Life is wonderful, I make the most of what I have."

Healthcare remains an important site of stigma. The researchers found that 40% of respondents had experienced negative treatment in a healthcare setting, including the use of excessive barrier protection, negative comments, and being given the last appointment of the day. Past problems were associated with being worried about future interactions with healthcare staff (anticipated stigma) and avoiding care, most often at a GP or dentist.

Compared with white British or Irish participants, people of other ethnicities experienced greater problems with disclosure and discrimination. Among people of other ethnicities, 21% had not disclosed their HIV status to anyone outside of healthcare settings, compared to 12% of white British or Irish people. When disclosure had occurred, they were less likely to feel that they had received appropriate support.

Among people of other ethnicities, 19% reported experiences of gossip, 16% sexual rejection, 10% verbal harassment, and 5% exclusion from social or family gatherings.

Women also reported more instances of stigma than men. They were especially likely to have concerns about the potential for gossip or sexual rejection (anticipated stigma). Perhaps as a result, 29% had avoided sex and 10% had avoided family gatherings.

"I haven’t felt comfortable not being open about it…I’ve found it really hard not being able to be completely honest with people."

Trans women (19 of whom took part) reported high levels of discrimination in healthcare settings.



L Thorley and A Hudson. Stigma in the age of undetectability. 21st International AIDS Conference (AIDS 2016). Durban, July 18-22. Abstract TUPED373.

P Kirwan, L Benton, W Crenna-Jennings, et al. The impact of resilience upon experiences of stigma: findings from the StigmaSurveyUK2015. 21st International AIDS Conference (AIDS 2016). Durban, July 18-22. Abstract THPED393.

W Crenna-Jennings, I Lut, D Asboe, et al. HIV-related stigma and discrimination in healthcare: findings from the STIGMASurveyUK 2015. 21st International AIDS Conference (AIDS 2016). Durban, July 18-22. Abstract TUPED399.

I Lut, W Crenna-Jennings, D Asboe, et al. HIV-related stigma within GP practices in the UK: findings from the STIGMASurveyUK 2015. 21st International AIDS Conference (AIDS 2016). Durban, July 18-22. Abstract TUPED401.

SG Ocala, W Crenna-Jennings, I Lut, et al. Experiences of disclosure and discrimination among black and other minority ethnic groups in the United Kingdom: findings from the STIGMASurveyUK 2015. 21st International AIDS Conference (AIDS 2016). Durban, July 18-22. Abstract THPED396.

W Crenna-Jennings, I Lut, D Asboe, et al. HIV-related stigma and discrimination among women: findings from the STIGMASurveyUK 2015. 21st International AIDS Conference (AIDS 2016). Durban, July 18-22. Abstract THPED416.